Ricevi le ultime notizie sulle azioni Alector con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di ALEC

Ultime notizie per

ALECTOR INC

Alector

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

AT&T-Photo by Jason Taylor AG via Shutterstock

Earnings

News

Pre-Market Outlook

Trading Ideas

ALEC

NFLX

Dopo il tonfo del gigante dello streaming e il crollo di un&#39;azienda biotech, l&#39;attenzione del mercato è tutta sulle trimestrali in arrivo.

La mattinata nera di Netflix e altri 4 titoli prima della campanella

Alector Inc

Health Care

Press Releases

Alector to Participate in Upcoming Healthcare Conferences

Alector Reports First Quarter 2025 Financial Results and Provides Business Update

Alector to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Management

Alector Provides Executive Leadership Update

Alector to Host Second Quarter and Mid-Year 2025 Earnings Conference Call

Alector Reports Second Quarter 2025 Financial Results and Provides Business Update

Alector to Host Virtual Research and Development Event Highlighting PGRN Franchise and Brain Carrier Programs

Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alector, Inc. - ALEC

Alpha Cognition

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Anika Therapeutics

Anixa Biosciences

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics

Compugen

Climb Bio

Coya Therapeutics

Cardiff Oncology

Citius Oncology

Elicio Therapeutics

Entera Bio

Fate Therapeutics

Forte Biosciences

TuHURA Biosciences

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Opus Genetics

Seres Therapeutics

MDxHealth

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Nuvectis Pharma

Spero Therapeutics

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

HC Wainwright & Co.

Mizuho

Morgan Stanley

Stifel

Comments

Alector Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO